Moodle
You are not logged in. (Login)
Skip Check this out...
Show or hide block

Check this out...

Welcome to E-Menai

12.5mg ambien cr KPA and APR have been granted patents that cover Cambia through 2026. Established in 1894, Kowa is actively engaged in various manufacturing and trading activities in the fields of pharmaceutical, life science, information technology, textiles, machinery and various consumer products. The Acurox Tablets NDA was originally accepted for filing by FDA earlier this year with a priority review classification.

.


NewsA Level

(KPA), a privately-held specialty pharmaceutical company headquartered in Montgomery, AL, announced today that the U., and a majority stake in the company was acquired by Kowa Company, Ltd. Its lead product, LIPOFENŽ (fenofibrate capsules), is indicated as adjunctive therapy to diet to reduce elevated triglycerides and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia. The Complete Response Letter raises issues regarding the potential abuse deterrent benefits of Acurox..